Author: Bram Bekaert

Categories
Industrial members

Takeda

Field of Expertise:
Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI)

Visit website

Field of Expertise:
Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI)

Visit website

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by their commitment to patients, their people and the planet.

Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). They also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

They are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging their enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.

Their employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

OTHER INDUSTRIAL MEMBERS

Categories
Conference 2023

Program

Download Program
abstract bundle
Register
Venue

Conference opening + Introductions

09h00 – 09h30

Registration & Welcome

Networking breakfast
Poster exhibition + booths

09h30 – 09h40

Conference opening

Sofie Bracke, Deputy Mayor of Ghent, responsible for Economy, Port and Sports

09h40 – 10h00

Introduction to CESPE & Update building

Prof. Thomas De Beer, CESPE Director
Dr. Christoph Portier, CESPE General Manager

PART 1:
Perspective from the pharmaceutical and biopharmaceutical Industry

– Goals – State-of-the-art – Bottlenecks –

Delegates from the big pharmaceutical and biopharmaceutical companies will highlight their company’s perspective on the current goals, state-of-the-art and bottlenecks related to their big investments in the transition towards sustainable manufacturing.

10h00 – 10h20

Environmental sustainability in the Small Molecules Active Pharmaceutical Ingredient’s
synthesis: from global policy into action.

Bert Heirman, Program Manager Strategic Sustainability Initiatives – Small Molecules, Janssen Pharmaceutica Geel
&
Bie Lambert, Head of Operations for Janssen Pharmaceutica Geel, Janssen Pharmaceutica Geel

10h20 – 10h40

Journey to a net-zero plasma derived manufacturing facility

Simon Gilleman, Sustainability Manager, Takeda

10h40 – 11h00

Coffee break

Poster exhibition + booths

11h00 – 11h20

(Preliminary) Sustainability in the Biomanufacturing Industry:
Global ambitions – Role of the big pharma – No-brainers – Struggles

David Vertongen, Sr. Technical Design Lead, Pfizer

11h20 – 11h40

Sustainability during Drug Product Manufacturing Development.

Jan-Sebastiaan Uyttersprot, PAT Principal Scientist, UCB Pharma

PART 2:
Contributions from Academic & Industrial stakeholders

– Chemical manufacturing – Biotech manufacturing – Drug Product Manufacturing –

Three consecutive sessions will be held where both academic and industrial stakeholders will showcase how their innovative approaches could play a crucial role in the sustainability advancements in different areas within pharmaceutical and biopharmaceutical manufacturing.

Session 1 – Chemical manufacturing

11h40 – 11h55

Digital technologies reducing the footprint in Pharma, examples from the Industry

Dirk Wollaert, Manager Business Development Pharma USA, Siemens Digital Industries

11h55 – 12h10

Transitioning to a more sustainable API development

Prof. Chris Stevens, Principal Investigator, CESPE

12h10 – 12h25

Towards a better process understanding and intensification by modeling

Prof. Joris Thybaut, Principal Investigator, CESPE

12h25 – 13h55

Networking lunch

Poster exhibition + booths


Session 2 – Biotech manufacturing

13h55 – 14h10

How Sustainability Meets Efficiency in Freeze-Drying

Mathieu Massart, Engineering Manager, RheaVita

14h10 – 14h25

Data, Artificial Intelligence & Analytics for Sustainable (Bio)Pharmaceutical Manufacturing.

Noah Nzuki, ESG Lead EMEA, Cognizant

14h25 – 14h40

Pharmaceutical Freeze-Drying: Innovations for a Smaller Ecological Footprint

Carolin Reinke, Senior Innovation Manager Pharma & Healthcare, GEA



Session 3 – Drug Product manufacturing

14h40 – 14h55

SUSTAIN: SUstainability STrAtegy ImplementatioN, from ESG to the working plant

Christian Post, Senior Process Engineer, VTU

14h55 – 15h10

Use of microfluidics to revolutionize the production of pharmaceuticals

Tim Dieryckx, CEO, Voxdale

15h10 – 15h25

The triple bottom line in healthcare: A holistic sustainability assessment for decision support

Prof. Delphine De Smedt, Principal Investigator, CESPE

15h25 – 15h45

Coffee break

Poster exhibition + booths

PART 3:
Staying ahead of what’s next

– Roundtable discussion – Innovation Café –

15h45 – 16h30

Roundtable discussion

Representatives from different key stakeholders groups will have an open discussion about the current challenges and innovations facilitating the transition towards sustainable pharmaceutical and biopharmaceutical manufacturing.
Get inspired by the insights of these key opinion leaders from industry, academia and policy makers.

Moderator

Tineke Van Hooland, Founder and CEO, Epic 10

Panel

Talia Flanagan, Head of Product Design and Performance, UCB Pharma
David Vertongen, Sr. Technical Design Lead, Pfizer
Simon Gilleman, Sustainability Manager, Takeda
Noah Nzuki, ESG Lead EMEA, Cognizant
Delphine De Smedt, Principal Investigator, CESPE
Isabelle Francois, Director Innovation, MEDVIA


16h30 – 17h20

Innovation Café

The talented people within CESPE will have the chance to pitch their innovative research to a broader audience.
Don’t miss this sneak-peek in the ongoing research within the different CESPE groups and member companies!

Take a look at the submitted abstracts for the Innovation Café.

Closing

17h20 – 17h30

Closing word

Prof. Dieter Deforce, Principal Investigator, CESPE

Networking Reception & Dinner

17h30 – …

Poster exhibition + booths

Categories
Industrial members

Pfizer Manufacturing Belgium

Field of Expertise:
Vaccines and sterile injectables

Visit website

Field of Expertise:
Vaccines and sterile injectables

Visit website

At Pfizer, they apply science and their global resources to bring therapies to people that extend and significantly improve their lives. They strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products.

Their global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

Consistent with their responsibility as one of the world’s premier innovative biopharmaceutical companies, they collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.

Their R&D Priorities and Strategy

  • Delivering a pipeline of highly differentiated medicines and vaccines where they have a unique opportunity to bring the most important new therapies to patients in need
  • Advancing their capabilities that can position them for long-term R&D leadership
  • Advancing new models for partnerships with creativity, flexibility and urgency to deliver innovation to patients as quickly as possible.

Pfizer Manufacturing Belgium, the largest production and packaging site of Pfizer worldwide, has now joined the CESPE Innovation cluster. The site has an extensive manufacturing setup with a range of formulation booths, filling lines, automatic inspection lines, packaging lines, freeze driers, and lab facilities. With their clinical pilot plant and experimental plant Pfizer Puurs is also known as a Launch Site within the Global Pfizer network, providing them the ability to quickly scale-up to commercial manufacturing of a new product.

OTHER INDUSTRIAL MEMBERS

Categories
Industrial members

Fette Compacting Belgium

Field of Expertise:
Technology innovator in OSD production for pharmaceutical and nutraceutical industry: tablet compression, continuous manufacturing equipment, capsule filling & containment solutions

Visit website

Field of Expertise:
Technology innovator in OSD production for pharmaceutical and nutraceutical industry: tablet compression, continuous manufacturing equipment, capsule filling & containment solutions

Visit website

Fette Compacting is a world-leading supplier of high-tech process equipment for the pharmaceutical industry.

Headquartered near Hamburg, with Sales & Service offices in all major markets, Fette Compacting designs, builds, sells and services worldwide sophisticated machines for the production of pharmaceutical tablets and capsules. The combination of high speed, high precision and full automation requires the very best engineering skills in the fields of mechanical, electronics, software and process design.

Fette Compacting Belgium, located in Mechelen, is the group’s innovation centre for the development and launch of new technologies and machines for faster and more precise pharmaceutical production.

OTHER INDUSTRIAL MEMBERS

Categories
News

Job Opportunity: Project Manager CESPE

🌍 Join our team and shape the future of sustainable pharmaceutical engineering and manufacturing! 🚀

Are you passionate about driving innovation in the pharmaceutical industry? Do you want to be part of a world-class team working towards sustainable manufacturing solutions? Look no further!

We are recruiting a Project Manager for the Centre of Excellence in Sustainable Pharmaceutical Engineering & Manufacturing (CESPE) at Ghent University. As CESPE strives to become the reference point for sustainable pharmaceutical production innovations globally, we need an exceptional individual to help us achieve our goals.

As a Project Manager, you will collaborate closely with our dynamic team, including the CESPE Director, Managing Director, Operational Manager, and Business Developers. You will play a vital role in attracting additional funding, coordinating subsidy reporting, supporting commercialization strategies, and fostering strong relationships with stakeholders.

Join us in building a sustainable future for pharmaceutical manufacturing.
Visit our website to learn more about CESPE and our exciting initiatives.


Get more information and apply here before June 30th. 

Categories
CESPE Academy Courses

Material characterization

Register here

COURSE OVERVIEW

This course gives an introduction on the (pharmaceutical) relevance of (raw) material characterization. An overview is given about the relevant characterization methods on the market, their applicability and how the material properties can be used to describe the processability.
This 1-day course consists out of a theoretical (interactive) and hands-on part.

MODULE 1: BASIC COURSE

Theoretical

The trainee will get an in-depth explanation about the different characterization methods, their (pharmaceutical) relevance and what you can do with the generated data.
Some of the key material characteristics described are:

Flow/cohesion
&
Particle size and shape
&
Density and porosity
&
Electrostatic charge
&
Melting point and crystal structure
&
Viscosity

Practical

Hands-on sessions will allow the trainee to get a feel with what it takes to characterize a material.
The extensive array of characterization equipments, available at CESPE, will be made available to visualize the difference between highly divergent powders.
Some of the equipment that will be used are:

FT4 Powder Rheometer
&
Schulze Ring Shear Tester
&
GranutoolsTM equipment
&
Malvern Laser diffractors
&
DVS and DSC equipment

Upon request, a powder of interest could be tested on the available equipment!
For more information, please contact Bram.Bekaert@UGent.be .

COURSE PROGRAM

A detailed overview of the course can be found in the following document.

Material-characterization-1Download

If you are interested in following this course, please take a look at planned sessions.
For further questions or requests, please use the contact form.

Categories
CESPE Academy Courses

Process Analytical Technologies

Register here

COURSE OVERVIEW

This course focusses on giving a thorough introduction about the implementation of PAT tools in the (bio)pharmaceutical industry.
This course is given in an interactive manner (both theoretical and hands-on) and can be divided into three separate modules:

Module 1: Basic course: Introduction to PAT implementation (1-day module)
&
Module 2: Advanced course: Data-analysis and modelling (Python) (2-day module)
&
Module 3: Specialized courses (1/2-day module)

Requirements
Basic understanding of spectroscopy and (bio)pharmaceutical processes
&
Basic understanding of coding and programming (python)

MODULE 1: BASIC COURSE

Theoretical

The trainee will get an in-depth explanation about the common (non-)spectroscopic PAT sensors and will learn how, when and where these tools can provide a benefit.

Spectroscopic PAT tools
&
Non-spectroscopic PAT tools
&
Hyperspectral imaging
&
PAT in R&D
&
Regulatory aspects
&
Multivariate data-analysis

Practical

The trainee will get the chance to see how PAT tools can be implemented and how this translates in a practical approach to acquire relevant process information.
Some of the tools that will be demonstrated are:

NIR
&
Raman
&
Other PAT devices

MODULE 2: ADVANCED COURSE

Theoretical

This module looks at the steps that follow after a successful implementation of the PAT tools. The trainee will learn on how to analyze and use the acquired data in multivariate models.

Introduction to Python
&
Data preparation
&
Linear and non-linear modelling
&
Multivariate data-analysis

Practical

During the course, the trainee will use placebo data sets to learn how to analyze and use the data.

MODULE 3: SPECIALIZED COURSES

In this module, the goal is to highlight specific examples, using real spectroscopic data in the form of use-cases.

Topics

Model predictive control
&
Unit operation-specific spectroscopic data-analysis
&
Bring your data to course day*

*The trainee has the option to bring his/her own data to the course. Together with the tutor they can go through the data and learn how to proceed.

COURSE PROGRAM

A detailed overview of the different modules can be found in the following document.

Process-Analytical-TechnologiesDownload

If you are interested in following this course, please take a look at planned sessions.
For further questions or requests, please use the contact form.

Categories
CESPE Academy Courses

Tableting 101

Register here

COURSE OVERVIEW

Tableting 101 focusses on giving a thorough introduction about the tableting process in an interactive manner (both theoretical and hands-on).
This course is divided into two separate modules:

Module 1: Basic course: Introduction to tableting (1-day module)
&
Module 2: Specialized courses (1-day module)

MODULE 1: BASIC COURSE

Theoretical

The trainee will get an in-depth explanation about the basic tableting aspects such as:

Tableting equipment
&
Tablet formulation
&
Tablet quality
&
Tableting process
&
Compaction mechanisms and models

Practical

Hands-on sessions will allow the trainee to get a feel with the tableting process and how this process can influenced by divergent factors.
The hands-on session will be performed on:

Compaction simulator
&
Rotary tablet press (MODULTM P)

MODULE 2: SPECIALIZED COURSES

In this module, the goal is to highlight specific aspects of the tableting process through different use-cases. Each use-case allows the trainee to get an in-depth comprehension of a specific part of the tableting process.

Topics

Lubrication (internal/external)
&
Sticking
&
Die filling
&
Compaction models
&
Upscaling of the tableting process

The trainee has the option to take up all of the provided topics, covering a full day course, or select a sub-set of these topics.

COURSE PROGRAM

A detailed overview of the different modules can be found in the following document.

Tableting-101Download

If you are interested in following this course, please take a look at planned sessions.
For further questions or requests, please use the contact form.

Categories
CESPE Academy Courses

Lyophilization 101

Register here

COURSE OVERVIEW

Lyophilization 101 focusses on giving a thorough introduction about pharmaceutical freeze-drying in an interactive manner (both theoretical and hands-on).
Throughout this 2-day course, the trainee gets to understand the basic and fundamental aspects from start untill finished product.

MODULE 1: BASIC COURSE

Theoretical – day 1

During the first day of the course, the trainee will get an in-depth explanation about the basic freeze-drying principles such as:

Freeze-drying equipment
&
Heat and mass transfer mechanisms
&
(Dis)advantages
&
Modelling of the freeze-drying cycle
&
Optimization of the process

Practical – day 1

Hands-on sessions will allow the trainee to get a feel with the freeze-drying process.
The hands-on session will cover:

Tour of the CESPE freeze-drying lab
&
Sample preparation and characterization
&
Starting your first run

Theoretical – day 2

During the second day, the focus will be put on PAT implementation and post-run analytics, allowing the trainee to deep-dive in the generated data.

Process analytical technologies (PAT)
&
Pre- and Post-run analytics
&
The future of freeze-drying: Continuous vs. Batch

Practical – day 2

Hands-on sessions during day 2 will mainly focus on the analysis of the performed run of practical day 1.
The hands-on session will cover:

Evaluation of the freeze-drying run
&
Water content determination
&
DSC
&
Sneak-peek at a continuous freeze-dryer

COURSE PROGRAM

A detailed overview of the program can be found in the following document.

Lyophilization-101Download

If you are interested in following this course, please take a look at planned sessions.
For further questions or requests, please use the contact form.

Categories
CESPE Academy Courses

Twin screw granulation 101

Register here

COURSE OVERVIEW

Twin screw granulation 101 focusses on giving a thorough introduction about the granulation process in an interactive manner (both theoretical and hands-on).
This course can be divided into three separate modules:

Module 1: Basic course: Introduction to twin screw wet granulation (1-day module)
&
Module 2: Basic course: Introduction to twin screw hot-melt granulation (1/2-day module)
&
Module 3: Specialized courses (1/2-day module)

MODULE 1: WET GRANULATION

Theoretical

The trainee will get an in-depth explanation about the basic twin screw wet granulation aspects such as:

Equipment overview
&
Principles of wet granulation
&
Batch vs continuous manufacturing
&
Process and formulation parameters
&
Granule characterization

Practical

The in-house ConsiGmaTM -25 line will be used to demonstrate the twin screw wet granulation process. Afterwards, the produced granules will be tested using the available granule characterization methods.
The hands-on session consists out of:

ConsiGmaTM-25 demonstration with placebo
&
Introduction to granule characterization methods

MODULE 2: HOT-MELT GRANULATION

Theoretical

The trainee will get an in-depth explanation about the basic twin screw hot-melt granulation aspects such as:

Equipment overview
&
Fundamentals of hot-melt granulation
&
Equipment configurations and settings
&
Pitfalls
&
Granule characterization*

*Will be skipped if module 1 was followed as well.

Practical

The trainee will be able to follow and help during placebo trials using a twin screw hot-melt granulator. The influence of process and formulation parameters will be demonstrated.

MODULE 3: SPECIALIZED COURSES

In this module, the goal is to highlight specific aspects of the granulation process through different use-cases. Each use-case allows the trainee to get an in-depth comprehension of a specific part of the process.

Topics

Wet granulation: Modified release formulations
&
Wet granulation: Impact of dry or wet addition

The trainee has the option to take up all of the provided topics, covering a half day course, or select a sub-set of these topics.

COURSE PROGRAM

A detailed overview of the different modules can be found in the following document.

Twin-screw-granulation-101Download

If you are interested in following this course, please take a look at the planned sessions.
For further questions or requests, please use the contact form.

Categories
CESPE Academy Courses

Feeding 101

Register here

COURSE OVERVIEW

Feeding 101 focusses on giving a thorough introduction about the feeding process in an interactive manner (both theoretical and hands-on).
This course is divided into two separate modules:

Module 1: Basic course: Introduction to feeding (1-day module)
&
Module 2: Specialized courses (1/2-day module)

MODULE 1: BASIC COURSE

Theoretical

The trainee will get an in-depth explanation about the basic feeding aspects such as:

Types of feeding equipment
&
Feeder accessories and their function
&
Types of feeder trials
&
Feeder data acquisition and analysis

Practical

During the hands-on sessions, the trainee will learn on how to install, operate and dismantel a loss-in-weight feeder.
The feeder demonstrations will be performed using two divergent materials.

Upon request, a powder of interest could be tested on the available equipment!
For more information, please contact Bram.Bekaert@UGent.be .

MODULE 2: SPECIALIZED COURSES

In this module, the goal is to highlight specific aspects of the feeding process through different use-cases. Each use-case allows the trainee to get an in-depth comprehension of a specific part of the process.

Topics

Surrogate approach for feeding
&
Impact of glidant addition
&
How specific configurations and settings can impact the feeding performance

The trainee has the option to take up all of the provided topics, covering a full day course, or select a sub-set of these topics.

COURSE PROGRAM

A detailed overview of the different modules can be found in the following document.

Feeding-101Download

If you are interested in following this course, please take a look at planned sessions.
For further questions or requests, please use the contact form.

Categories
News

PhD vacancy

One of the CESPE research groups (The Laboratory of Pharmaceutical Technology) is recruiting a full-time Ph.D. student in the field of continuous manufacturing of pharmaceuticals.

You will have the chance to play an important role within the domain of pharmaceutical technology, more specifically in the field of (continuous) manufacturing of pharmaceutical dosage forms.
During your Ph.D. you will get the chance to publish your research data in international peer-reviewed papers; assist in the teaching activities at the Laboratory of Pharmaceutical Technology, including the guidance of master dissertations; and assist in the internal and external services by the Laboratory of Pharmaceutical Technology.

Don’t hesitate to take a look at the vacancy.

Categories
News

Master of Science in Pharmaceutical Engineering (MPE) is accepting applications!

Ghent University is now accepting applications for our Master of Science in Pharmaceutical Engineering (MPE) program. Our program offers a unique combined training of pharmaceutical and engineering skills. Both skills are required to develop these pharmaceutical production processes for tomorrow’s drug products and supply needs.
The MPE consists of a two-year English-taught programme of 120 credits and will help you acquire all skills and knowledge that you need to implement novel manufacturing concepts that require a high degree of digitalization and automation. The MPE will also increase your opportunities to get a good position in the pharmaceutical industry or to become an excellent PhD candidate!

For further information, please take a look at the MPE site: https://lnkd.in/gXFbn42H.

FlyerDownload
Categories
Industrial members

Janssen Pharmaceutica

Field of Expertise:
R&D, manufacturing and new product launch

Visit website

Field of Expertise:
R&D, manufacturing and new product launch

Visit website

The Janssen campus in Belgium (or Janssen Pharmaceutica) is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. A unique fusion of expertise, capabilities and partnerships in R&D, manufacturing and new product launch. Together, they are creating a future where disease is a thing of the past.

As an innovative campus, they focus on important fields of research such as neuroscience, oncology, immunology, infectious diseases, cardiovascular and metabolism and pulmonary hypertension. Fields in which the unmet medical need is high and much is to be done and to achieved.

Janssen in Belgium has been focusing on research and development for more than 60 years. The campus in Belgium has been instrumental in the discovery and development of a new generation of tuberculosis, HIV/AIDS, cancer, infectious diseases and neurological drugs. It was here in Beerse that the first FDA-approved tuberculosis drug in 40 years was discovered and developed.

From early research and development, through supply chain to patient access – their people are making an important contribution to the health of many.

OTHER INDUSTRIAL MEMBERS

Categories
Industrial members

Cognizant

Field of Expertise:
IT services and IT consulting

Visit website

Field of Expertise:
IT services and IT consulting

Visit website

Cognizant engineers modern businesses. They help their clients modernize technology, reimagine processes and transform experiences so they can stay ahead in the fast-changing world.

Cognizant uses expertise that’s been proven and tested around the globe to help their customers get ahead of challenges, sense opportunities sooner and outpace change.

They develop game-changing digital solutions in many different fields of expertise:

  • Digital Engineering
  • Intelligent Process Automation
  • Industry & Platform Solutions
  • Internet of Things
  • Artificial Intelligence
  • Cloud
  • Data
  • Life Sciences
  • Healthcare
  • Manufacturing
  • Technology
  • …

OTHER INDUSTRIAL MEMBERS

Categories
Conference 2023 News

CESPE Conference 2023

Challenges & Solutions for transitioning to sustainable (bio)pharmaceutical manufacturing

Download Program
Register
Venue

CESPE is pleased to announce the second edition of the annual CESPE Conference on Thursday September 21, 2023.

Through insights from different stakeholders, this event aims to address and tackle the current challenges related to the transition into a more sustainable (bio)pharmaceutical industry.

  • What are the goals for the industry and which initiatives are being taken by the (bio)pharmaceutical companies?
  • Where are the current bottlenecks limiting innovation and how can we solve them?
  • Which tools are required to achieve ambitious goals?
  • What is the role of both academic and industrial partners?

The physical event in Ghent will provide you with many opportunities to network with our academic members, industrial partners and policy makers. Therefore, it is perfectly suited for senior scientists, industrial decision makers and policy makers active within the ecosystem.

Check out the program below and stay tuned for further details!

For further information on booths and sponsorships, feel free to contact Christoph Portier (Christoph.Portier@UGent.be) or Bram Bekaert (Bram.Bekaert@UGent.be).

Categories
Industrial members

AM-Team

Field of Expertise:
Advanced modelling services for process optimisation and design

Visit website

Field of Expertise:
Advanced modelling services for process optimisation and design

Visit website

AM-Team was founded in 2017 by Dr. Wim Audenaert, Dr. Usman Rehman, and Prof. Ingmar Nopens, all having MSc and PhD degrees in either chemical or environmental engineering. AM-Team is a spinoff company of Ghent University with over a decade of expertise in process modelling and simulations.

Customers from all over the globe rely on their leading-edge simulation services and digital tools. They keep on developing tailored digital solutions to match the needs of their customers in the process industry.

They do this by: 

  • Developing new process models and methodologies to maximise customer experience and cater the industry needs
  • Sharing their expertise at high-level international events and publishing new findings in peer-reviewed scientific papers, often together with customers
  • Investing in new hardware and software to maximise simulation speed and accuracy

Thanks to their large team of dedicated simulation engineers, they can handle large projects in a short timeframe. 

OTHER INDUSTRIAL MEMBERS

Categories
Industrial members

Secoya Technologies

Field of Expertise:
Crystallization, emulsification, pervaporation, process intensification

Visit website

Field of Expertise:
Crystallization, emulsification/encapsulation, pervaporation, process intensification

Visit website

Secoya Technologies is a global provider of services and equipment in particle engineering for the (bio)-pharmaceutical industry. Secoya’s experts have been developing innovative production technologies and equipment by a smart use of micro-structured elements, enabling a faster, precise and secure development and production process.

Their ranges of robust intensified reactors guarantee a stable and reliable production process – at different scale – of high quality (bio-)pharmaceutical products. Their core principle is applied to following technologies and in-house expertise service:

  • Crystallization (small molecules, API, excipients…)
  • Emulsification / Encapsulation (simple and double emulsion for encapsulation of biomolecules, API…)
  • Pervaporation
  • Process intensification

The integration of their unique, robust and versatile technologies in their equipment, combined with their unique know-how, allows them to guide their partners with mastering every aspect of the manufacturing process, from laboratory scale to commercial production scale the size of the particles generated and their size distribution as well as to increase the efficiency, productivity and flexibility. Whether it is the development of new products or the improvement of existing products, Secoya’s technologies provide many key benefits:

  • Unmatched product quality and secure production
  • Implementation of Quality-by-Design
  • Reduction of investment cost and risk for the process development
  • Reduction of cost of goods sold
  • Inherent compatibility with continuous manufacturing
  • Manufacturing of new possible molecules

OTHER INDUSTRIAL MEMBERS

Categories
Industrial members

RheaVita

Field of Expertise:
Continuous & controlled freeze drying

Visit website

Field of Expertise:
Continuous & controlled freeze drying

Visit website

RheaVita sells single vial (for R&D), non-GMP multi-vial (for scale-up and stability studies), and full GMP continuous freeze-drying systems.

Next to our engineered solutions we also offer freeze-drying related CDMO services. The freeze-drying of biopharmaceuticals, LNP-based formulations, ATMPs, and other small and large molecules, requires proper formulation and process optimization of the drug substance. Designing the optimal formulation based on the drug substance properties and characteristics is crucial. Furthermore, by applying a model-based strategy, RheaVita provides the opportunity to efficiently design and optimize your freeze-drying process in an extremely fast way with limited product consumption. 

Our manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-patient, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance thanks to PAT (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.

RheaVita has also set up an academy to share knowledge on freeze-drying where our customers receive a fundamental insight into freeze-drying and analysis of the results and experience the benefits of continuous manufacturing technology.

OTHER INDUSTRIAL MEMBERS

Categories
News

Professor Dieter Deforce and CESPE join hands

It is with great honour that we can announce professor Dieter Deforce as a new academic member of CESPE. His expertise in the fields of pharmaceutical biotechnology and (forensic) DNA-analysis are a crucial addition to the CESPE portfolio.

Dieter Deforce is a professor at the University of Ghent and is the head of the Laboratory of Pharmaceutical Biotechnology at the Faculty of Pharmaceutical Sciences. From 2001 till 2016 he was also head of the forensic DNA‐analysis laboratory, which he founded at the University of Ghent, accredited and recognized by the Belgian government. He remains in the forensic field as dedicated DNA expert.

He is chair of the Belgian Medicines Committee, member of the Scientific Advise Working Party of the European Medicines Agency. He is also the director of the ProGenTomics platform of the University of Ghent, providing amongst others proteomics and mainly mass spectrometry based protein analytical tools to the research community. He is a partner in NXT‐GNT, a research consortium providing the research community next generation DNA‐sequencing. He is member of the board of directors of the VIB.

His research focuses on applying proteomics and genomics platforms (including Next Generation Sequencing) in the field of post translational protein modifications, stem cell development, prenatal genetic diagnosis, (auto‐)immunity and forensics and he is (co‐)author of over 350 scientific papers.

Categories
Team

Dr. Bram Bekaert

Cespe Project Manager, Operations

Ghent University
Centre of Excellence in Sustainable Pharmaceutical Engineering & Manufacturing
Faculty of Pharmaceutical Sciences
Campus Heymans
Ottergemsesteenweg 460
B-9000 Gent, Belgium

bram.bekaert@ugent.be

+32 9 264 81 18

Bram Bekaert is Operational Manager at the Centre of Excellence in Sustainable Pharmaceutical Engineering and Manufacturing (CESPE). He will focus on technical support for the CESPE Innovation Accelerator & Incubator, attracting additional funding for the further development of the CESPE Innovation Accelerator & Incubator, and coordinating grant reporting to the Department of Economy Science and Innovation (EWI). Additionally, he will have a supporting role in attracting industrial partners for commercialisation of the CESPE Incubator and maintaining relationships with internal and external policymakers.

After obtaining his Master in Drug Development, Bram Bekaert continued his pharmaceutical career as a PhD researcher at the Laboratory of Pharmaceutical Technology. His PhD research, in collaboration with Janssen Pharmaceutica (Belgium) and Fette Compacting Belgium, focused on improving process knowledge about continuous direct compression with a core focus on the feeding and blending unit. Additionally, he gained experience in material characterization, PAT implementation and hot melt granulation. Bram Bekaert obtained his PhD in 2021 and decided to remain at the faculty as a postdoctoral researcher where he continued his focus on continuous direct compression as part of the Laboratory of Pharmaceutical Engineering.

Categories
Team

Dr.Ir. Sarah Costers

Project Manager

Ghent University
Centre of Excellence in Sustainable Pharmaceutical Engineering & Manufacturing
Faculty of Pharmaceutical Sciences
Campus Heymans
Ottergemsesteenweg 460
B-9000 Gent, Belgium

Sarah.Costers@UGent.be

+32 9 264 81 18

Sarah Costers joined the CESPE team as project manager with expertise in discovery and development of biologics.

Sarah graduated as bioengineer cell and gene biotechnology and obtained a PhD in veterinary science in the field of virology/immunology, both at Ghent University. After 14 years of R&D in the biotech/pharma industry, she now returns to the alma mater/CESPE to facilitate and organize knowledge exchange and collaboration between industry and academia via strategic projects. She will attract additional funding for the equipment of the CESPE Innovation accelerator and incubator and provide support for the commercialization of the CESPE Innovation incubator.  

Categories
Team

Dr. Bart Hommez

Business Developer

Ghent University
Industrial Research Fund
Tech Lane Ghent Science Park - Campus Ardoyen
Technologiepark 125
B-9052 Zwijnaarde-Gent, Belgium

Bart.Hommez@UGent.be

+32 9 264 96 03

Bart Hommez obtained his PhD in Chemistry (polymer chemistry) from Ghent University. After his PhD he worked for 10 years within the lubricants industry (automotive and industrial applications), followed by 3 years in innovation consulting for SME’s. Today Bart is active as business developer for Ghent University where he leads the exploitation of research output in close collaboration with the research teams within the field of chemical engineering and modelling.

Categories
Team

Prof. Dr. Ir. Jeroen Lauwaert

Principal Investigator

Ghent University
Industrial Catalysis and Adsorption Technology (INCAT)
Department of Materials, Textiles and Chemical Engineering
Valentin Vaerwyckweg 1
B-9000 Gent, Belgium

Jeroen.Lauwaert@ugent.be

+32 9 243 25 22

Jeroen Lauwaert is an assistant professor in sustainable industrial chemistry at the Industrial Catalysis and Adsorption Technology research group of Ghent University, since September 2021. He started his doctoral research, on the design of cooperative acid-base catalysts for aldol reactions, at the Laboratory for Chemical Technology (LCT) in collaboration with the Center for Ordered Materials, Organometallics and Catalysis (COMOC) at the same university, in 2011. In 2014, he gained international experience while working in the group of prof. Jones in Atlanta, USA. Following the completion of his PhD in 2015, he joined Ghent University’s Industrial Catalysis and Adsorption Technology (INCAT) research group as a postdoctoral assistant. In 2017 and 2020, his expertise in the broad field of chemical engineering, ranging from heterogenous catalysis and reaction engineering to thermodynamics and separation train design, was honored by FWO (Research Foundation – Flanders) with, respectively, a junior and a senior postdoctoral fellowship. In 2021, he was appointed as part-time (50%) assistant professor.

Today, prof. Lauwaert supervises 10 young researchers who primarily focus on process intensification for applications spanning from biomass valorisation to fine chemical and pharmaceutical industries. His research activities comprise a wide spectrum of fields.

One of the major themes is heterogeneous catalysis and reaction engineering, which involves synthesizing and characterizing catalysts and testing their performance in terms of activity, selectivity, and stability. Additionally, he develops intrinsic kinetic and industrial reactor models to optimize reaction conditions and design catalysts.

Secondly, prof. Lauwaert has expertise in adsorption technologies for the recovery of high value components that are present in low concentrations in waste streams. Furthermore, he aims to unravel the thermodynamics of molecules containing multiple functionalities and/or heteroatoms by developing thermodynamic models that can be applied to separation train design. Finally, a minor research topic of prof. Lauwaert aims at developing multidimensional chromatographic analysis techniques (liquid and gas) for complex mixtures, e.g., non-volatile aromatics.

Categories
Team

Prof. Dr. Paul Van Liedekerke

principal investigator

Ghent university
Faculty of Bioscience Engineering
Department of Data analysis and mathematical modelling
Coupure Links 653
9000 Gent

Paul.VanLiedekerke@UGent.be

+32 (0)9 264.59.32

Prof. dr. Paul Van Liedekerke is assistent professor at Ghent University. He holds a MSC in physics (University of Ghent), a PhD in bio-engineering (KULeuven) and a Habilitation from Sorbonne University, Paris.

Paul has worked at KULeuven (2001-2011) where has developed Discrete Element Methods to simulate granular flows in machinery, as well as Computation Fluids dynamics methods to simulate complex fluids.  From 2012 to 2022 he worked at INRIA de Paris as expert engineer where he created models and software to predict cellular growth (in vitro and in-vivo)  and living tissue development. During these years he collaborated with industrial partners on several occasions.

His interests and expertise lie in developing numerical models and new conceptual ideas such as hybrid modelling and digital twins, and applying those techniques in industry and medicine.  In a nutshell: simulations of granular flow and powders, simulations of cell growth and living tissues, simulations of bioreactors: cell yield and biologics, and software development.

Categories
Research groups

DySC

Field of Expertise:
Modelling, process control, identification, multi-objective process optimization, multivariable control

Visit website

The Dynamical Systems and Control (DySC) group has research expertise on modelling and control of dynamical systems in several application fields from biomedical to industrial processes.

In the last years the group of Prof. Ionescu has focused on the application of fractional order control as an intermediate control strategy for industry and manufacturing processes, between basic control (such as PID type) and advanced control (such as MPC). Part of this scope is the industrial relevant implementations of MPC and multi-objective optimization algorithms as a function of changing operating context.

Furthermore, there is an ongoing ERC Consolidator grant focusing on the use of computer based constrained optimization of multi-drug infusion rates for anesthesia with strong effects on hemodynamics.

As current topics, the DySC group focusses on modelling and control of dynamical systems with application fields in:

  • Biomedical
  • Chemical
  • Pharmaceutical
  • Mechanical
  • …
Categories
Research groups

Epidemiology of Chronic Diseases

Field of Expertise:
Burden of disease, patient-reported health outcomes, health economic techniques

Visit website

The Epidemiology of Chronic Diseases Research Unit conducts several research projects relating to disease prevention and burden including risk factors epidemiology, lifestyle changes, risk management, physical activity at work and psychosocial risk factors.

The Unit is in close collaboration with the Belgian institute for health Sciensano (Brussels), the National Research Centre for the Working Environment Copenhagen, Jožef Stefan Institute Ljubljana, Imperial College London, Karolinska Institute Stockholm and University of Galway, with whom it shares several projects on the epidemiology and prevention of major health problems in developed and developing countries.

Within the faculty of Medicine and Health sciences, the department of Public Health and Primary Care is internationally renowned for its research in health economics and epidemiology. The research of Prof. Delphine De Smedt, associate Professor, is mainly focused on the burden of disease, patient-reported health outcomes and health economic techniques. She has experience in developing health economics models in different chronic disease areas.

Categories
Research groups

INCAT

Field of Expertise:
Heterogeneous catalysis, reaction engineering, adsorption technology, thermodynamics, separation train design, applied multidimensional chromatography

Visit website

The Industrial Catalysis and Adsorption Technology research group (INCAT) is part of the Materials, Textiles, and Chemical Engineering department (MaTCh, EA11) within the Faculty of Engineering and Architecture at Ghent University. INCAT primarily focuses on the development of catalysts and adsorbents, with a strong emphasis on renewable resources and environmental management. A major objective is the catalytic conversion of biomass-derived streams, encompassing their upgrading and separation into valuable chemicals. INCAT’s research endeavours have a practical, application-oriented approach, addressing the specific needs of industries. To achieve this, the group actively collaborates with consortiums and industrial partners, including small and medium-sized companies in the broader chemical industry.

INCAT encompasses a diverse range of expertise across various chemical engineering domains. INCAT specializes in heterogeneous catalysis and reaction engineering, involving the synthesis, characterization, and performance testing of catalysts, as well as developing intrinsic kinetic and industrial reactor models to optimize reaction conditions and design efficient catalysts.

The research group also has extensive knowledge in adsorption technologies and focusses on developing methods to recover high-value components from waste streams that are present in low concentrations. By designing and implementing efficient adsorbents and recovery techniques, INCAT contributes to sustainable resource management.

Thermodynamics and separation train design also form an essential part of INCAT’s expertise, as the group delves into the thermodynamics of molecules containing multiple functionalities and/or heteroatoms, creating thermodynamic models that aid in the design of effective separation trains for various chemical processes.

Additionally, INCAT explores the development of multidimensional chromatographic analysis techniques, encompassing both liquid and gas phases to enable the analysis of complex mixtures, such as non-volatile aromatics, providing valuable insights for various applications.

Categories
Research groups

Supramolecular Chemistry Group

Field of Expertise:
Polymer chemistry and polymer materials

Visit website

The research of the Supramolecular Chemistry Group (Ghent University) focuses on the molecular design of polymer materials for a broad range of applications, including drug delivery, biomaterials and excipients. The group has a strong expertise in the synthesis of defined (functional) polymer structures with a special emphasis on poly(2-oxazoline)s, responsive polymers and supramolecular materials.

Some illustrative examples of relevant projects are listed below:

  • Poly(2-oxazoline) matrix excipients for oral dosage forms enabling high drug loading (up to 70%-80) amorphous solid dispersions of poorly water-soluble drugs, such as flubendazole, mebendazole and fenofibrate
  • Poly(2-oxazoline) matrix excipients for oral dosage forms enabling high drug loading (up to 70%) sustained release formulations of drugs with good water solubility, such as metoprolol tartrate and metformin
  • Cationic polymers for transfection of pDNA, siRNA, mRNA and saRNA enabling better in vitro transfection than lipofectamine and similar in vivo transfection as lipid nanoparticles
  • Polymer-drug conjugates to reduce systemic toxicity and enhance blood circulation time, possibly in combination with targeting ligands, including antibody-drug conjugates
  • Polymer-protein conjugates to enhance blood circulation time and enhance protein stability
  • Responsive polymers that are insoluble in the blood stream but rapidly solubilize upon cell internalization, through either protonation or degradation of side chains under mild acidic conditions